HLOSF
Price:
$1.8
Market Cap:
$29.61B
Healios K.K. is a biotechnology firm specializing in the innovation, development, production, and commercialization of cell therapy and regenerative medicine products, with operations spanning Japan, Europe, and the United States. The company's robust pipeline features several advanced cellular and tissue-based therapies: iPSC-derived regenerative medicines HLCR011 and HLCR012, which target age-related macular degeneration; HLCL041, an iPSC regenerative medicine for metabolic liver disease; HLCM051, a regenerative treatment for ischemic stroke and acute respiratory distress syndrome; and HLCN061, currently under development for solid tumor indications. Furthermore, Healios K.K. maintains a c...[Read more]
Industry
Biotechnology
IPO Date
2020-11-09
Stock Exchange
OTC
Ticker
HLOSF
According to Healios K.K.’s latest financial reports and current stock price. The company's current Enterprise Value is 21.33B. This represents a change of -48.32% compared to the average of 41.27B of the last 4 quarters.
The mean historical Enterprise Value of Healios K.K. over the last ten years is 52.28B. The current 21.33B Enterprise Value has changed 3.98% with respect to the historical average. Over the past ten years (40 quarters), HLOSF's Enterprise Value was at its highest in in the December 2020 quarter at 98.61B. The Enterprise Value was at its lowest in in the December 2023 quarter at 10.11B.
Average
52.28B
Median
65.55B
Minimum
9.03B
Maximum
98.62B
Discovering the peaks and valleys of Healios K.K. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 152.64%
Maximum Annual Enterprise Value = 98.62B
Minimum Annual Increase = -76.40%
Minimum Annual Enterprise Value = 9.03B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 26.43B | 80.40% |
| 2024 | 14.65B | 62.24% |
| 2023 | 9.03B | -40.50% |
| 2022 | 15.18B | -76.40% |
| 2021 | 64.31B | -34.80% |
| 2020 | 98.62B | 47.65% |
| 2019 | 66.80B | -9.86% |
| 2018 | 74.10B | 4.68% |
| 2017 | 70.79B | -14.66% |
| 2016 | 82.94B | 152.64% |
The current Enterprise Value of Healios K.K. (HLOSF) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
16.70B
5-year avg
25.92B
10-year avg
52.28B
Healios K.K.’s Enterprise Value is greater than Avacta Group Plc (330.19M), greater than BioInvent International AB (publ) (1.16B), greater than Northwest Biotherapeutics, Inc. (374.44M), greater than PureTech Health plc (189.27M), greater than MedinCell S.A. (1.04B), greater than CytoDyn Inc. (395.10M), greater than Immutep Limited (149.97K), greater than Clinuvel Pharmaceuticals Limited (455.20M), greater than Cresco Labs Inc. (815.39M), greater than Cellectis S.A. (299.45M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 330.19M | $454.97M | |
| 1.16B | $216.40M | |
| 374.44M | $312.23M | |
| 189.27M | $413.81M | |
| 1.04B | $1.23B | |
| 395.10M | $383.53M | |
| 149.97K | $73.69M | |
| 455.20M | $348.84M | |
| 815.39M | $290.46M | |
| 299.45M | $251.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Healios K.K. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Healios K.K. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Healios K.K.'s Enterprise Value?
What is the highest Enterprise Value for Healios K.K. (HLOSF)?
What is the 3-year average Enterprise Value for Healios K.K. (HLOSF)?
What is the 5-year average Enterprise Value for Healios K.K. (HLOSF)?
How does the current Enterprise Value for Healios K.K. (HLOSF) compare to its historical average?